Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis Giuseppe ScalabrinoDaniela Veber Review 20 October 2013 Pages: 1451 - 1460
Pharmacological therapies in post stroke recovery: recommendations for future clinical trials F. CholletS. C. CramerH. Adams Jr Review 13 November 2013 Pages: 1461 - 1468
Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study Peter Joseph JongenDirk LehnickThe FOCUS Extension Study Group Original Communication Open access 03 May 2014 Pages: 1469 - 1476
Safety and feasibility of nucleus accumbens stimulation in five patients with epilepsy Friedhelm C. SchmittJuergen VogesAlexander B. Kowski Original Communication Open access 07 May 2014 Pages: 1477 - 1484
Comparison of monoclonal gammopathy of undetermined significance-associated neuropathy and chronic inflammatory demyelinating polyneuropathy patients Nuha M. AlkhawajahSamantha K. DunniganVera Bril Original Communication Open access 07 May 2014 Pages: 1485 - 1491
Health services utilization of patients with vertigo in primary care: a retrospective cohort study Eva GrillMichael StruppKlaus Jahn Original Communication 11 May 2014 Pages: 1492 - 1498
The association between TOMM40 gene polymorphism and spontaneous brain activity in amnestic mild cognitive impairment Xiaoyan LiuFeng BaiZhijun Zhang Original Communication 18 May 2014 Pages: 1499 - 1507
Mortality of patients with multiple sclerosis: a cohort study in UK primary care S. S. JickL. LiM.-A. Wallander Original Communication Open access 18 May 2014 Pages: 1508 - 1517
Erratum to: Mortality of patients with multiple sclerosis: a cohort study in UK primary care S. S. JickL. LiM.-A. Wallander Erratum 03 July 2014 Pages: 1518 - 1521
Retinal alterations in mild cognitive impairment and Alzheimer’s disease: an optical coherence tomography study Francisco J. AscasoNancy CruzJosé A. Cristóbal Original Communication 21 May 2014 Pages: 1522 - 1530
Auditory neuropathy in individuals with Type 1 diabetes Gary RanceDonella ChisariDavid Szmulewicz Original Communication 21 May 2014 Pages: 1531 - 1536
The cognitive spectrum in neurodegenerative Langerhans cell histiocytosis Loïc Le GuennecCaroline DecaixAhmed Idbaih Original Communication 22 May 2014 Pages: 1537 - 1543
The gender-specific association of CXCL16 A181V gene polymorphism with susceptibility to multiple sclerosis, and its effects on PBMC mRNA and plasma soluble CXCL16 levels: preliminary findings Ljiljana StojkovićAleksandra StankovićMaja Živković Original Communication 23 May 2014 Pages: 1544 - 1551
Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation Franca TecchioAndrea CancelliMaria Maddalena Filippi Original Communication 23 May 2014 Pages: 1552 - 1558
Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab Brett J. TheelerBenjamin EllezamJohn F. de Groot Original Communication 25 May 2014 Pages: 1559 - 1564
GD1b-specific antibodies may bind to complex of GQ1b and GM1, causing ataxia Nobuhiro YukiYuki FukamiKoichi Hirata Original Communication 25 May 2014 Pages: 1565 - 1569
Stroke in sports: a case series Gonçalo M. AlexandrinoJoana DamásioJosé M. Ferro Original Communication 03 June 2014 Pages: 1570 - 1574
Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study Milica Jecmenica-LukicIgor N. PetrovicVladimir S. Kostic Original Communication 03 June 2014 Pages: 1575 - 1583
Progressive myoclonus epilepsy in Down syndrome patients with dementia Giuseppe d’OrsiLuigi M. SpecchioOn behalf of the Apulian Study Group on Senile Myoclonic Epilepsy Original Communication 04 June 2014 Pages: 1584 - 1597
Measuring disease progression in corticobasal syndrome Nancy HuangMichael HornbergerJames R. Burrell Original Communication 04 June 2014 Pages: 1598 - 1605
MP2RAGE provides new clinically-compatible correlates of mild cognitive deficits in relapsing-remitting multiple sclerosis Samanta SimioniFabio AmarùCristina Granziera Original Communication 10 June 2014 Pages: 1606 - 1613
How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up F. PurroyP. E. Jiménez CaballeroJ. Masjuán Original Communication 10 June 2014 Pages: 1614 - 1621
Age dependency of safety and outcome of endovascular therapy for acute stroke Rudolf LuediKety HsiehSimon Jung Original Communication 11 June 2014 Pages: 1622 - 1627
Cerebral microbleeds in patients with Parkinson’s disease Jee Hyun HamHan YiPhil Hyu Lee Original Communication 12 June 2014 Pages: 1628 - 1635
Relapse of tardive dystonia after globus pallidus deep-brain stimulation discontinuation Sébastien BoulogneTeodor DanailaStéphane Thobois Letter to the Editors 12 June 2014 Pages: 1636 - 1637
Current state of diagnostic management of acute vertigo: a survey of neurologists in Germany Christoph HelmchenBjörn MachnerAndreas Sprenger Letter to the Editors 13 June 2014 Pages: 1638 - 1640
Verapamil-responsive coital cephalalgia as reversible cerebral vasoconstriction prodrome Nicholas H. ChiaTimothy J. Kleinig Letter to the Editors 24 June 2014 Pages: 1641 - 1643
Narcolepsy: environment, genes and treatment K. J. PeallN. P. Robertson Journal club 18 July 2014 Pages: 1644 - 1646
Theodor Meynert (1833–1892) Hassan YarmohammadiGolnoush Sadat Mahmoudi NezhadAhmad Ghanizadeh Pioneers in Neurology 21 August 2013 Pages: 1647 - 1648
Robert Bartholow (1831–1904) Marco CambiaghiStefano Sandrone Pioneers in Neurology 23 August 2013 Pages: 1649 - 1650